Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/2003
06/11/2003EP0950053B1 New derivatives of benzoylalkyl-1,2,3,6-tetrahydropyridins
06/11/2003CN1423748A Solution and crystal structures of MMP-13 active sidte and uses thereof
06/11/2003CN1423695A Antisense oligonucleotides
06/11/2003CN1423657A Inter feron-alpha induced gene
06/11/2003CN1423651A New use and novel N-azabicyclo-amide derivatives
06/11/2003CN1423647A Beta-alanine derivatives and their use as receptor antagonists
06/11/2003CN1423646A Hetero cyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
06/11/2003CN1423642A Oxy-and amino-substituted tetrahydrofurl derivatives with antitumour activity
06/11/2003CN1423639A Solid state forms of 5-[[6-[(2-Fluorophenyl) methoxy]-2-naphthalenyl] methyl]-2,4-Thiazolidinedione
06/11/2003CN1423638A Ox (adi) azolyl-hydroxamic acids useful as procollagen C-proteinase inhibitors
06/11/2003CN1423565A 精子因子oscillogenin Sperm factor oscillogenin
06/11/2003CN1423563A Pancreatic stem cells and their use in transplantation
06/11/2003CN1423560A Male contraceptive formulation comprising norethisterone
06/11/2003CN1423559A Controlled-release compositions containing opioid agonist and antagonist
06/11/2003CN1423557A Intracorporeal medicaments for photodynamic treatment of disease
06/11/2003CN1423550A Cosmetic compositions containing chick pea extract and retinoids
06/11/2003CN1422870A Fusional protein with intensified activity of internal red-blood-cell formation element
06/11/2003CN1422849A 吲唑衍生物 Indazole derivative
06/11/2003CN1422657A Chinese medicine capable of making cultured prawn quickly shelling and disinfecting water thereof
06/11/2003CN1422637A Health-care product for improving sleep and increasing bone density
06/11/2003CN1422626A Pseudo-ginseng instant powder and its preparation method
06/11/2003CN1422612A Nano-grade medicine controlled-releasing technology and preparation and use for viformicoid preparation
06/10/2003US6576793 β2-adrenergic receptor agonists
06/10/2003US6576762 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
06/10/2003US6576758 Nucleic acid constructs containing hybrid promoters
06/10/2003US6576752 Aminooxy functionalized oligomers
06/10/2003US6576751 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
06/10/2003US6576745 Human cystatin F antibodies
06/10/2003US6576671 Left ventricular dysfunction; 5,6-dihydroxy- or 5,6-diiso-butyroloxy-2-methylaminotetralin
06/10/2003US6576670 Administering 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one-ortho-2 -(dimethylaminoethyl)-oxime or its hemi-fumerate salt
06/10/2003US6576669 Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes
06/10/2003US6576666 First fatty acid compound that is a linoleic or linolenic compound and a second fatty acid that is a docosahexaenoic acid compound, an omega-3 or an omega-2 fatty acid or derivative
06/10/2003US6576660 Methods and compositions for regulation of 5-α-reductase activity
06/10/2003US6576658 Compositions and uses of dictyostatin compounds
06/10/2003US6576657 Amidino derivatives and their use as thrombin inhibitors
06/10/2003US6576655 To produce polymers; cancer therapy
06/10/2003US6576653 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
06/10/2003US6576651 Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones
06/10/2003US6576650 No central nervous system side effects
06/10/2003US6576648 Compound with growth hormone releasing properties
06/10/2003US6576645 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
06/10/2003US6576644 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
06/10/2003US6576641 For therapy and prophylaxis of Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), or a neurodegenerative disease of the eye, including photoreceptor loss in retina
06/10/2003US6576640 Rapidly penetration into central nervous system; treating noradrenaline deficiency; depression, Parkinson's disease
06/10/2003US6576637 Such as 3-(4-methyl-3-nitrophenyl)-3-(2-(4-(pyridin-2-yl-amino)butyryl amino)acetylamino)propionic acid; thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, inflammations,
06/10/2003US6576630 Compounds and compositions as protease inhibitors
06/10/2003US6576628 Matrix metalloprotease inhibitors; arthritis, corneal ulcers, arteriosclerosis
06/10/2003US6576627 Phosphonic acid derivatives having carboxypeptidase b inhibitory activity
06/10/2003US6576626 Treating gastro-oesophageal reflux disease
06/10/2003US6576624 Administering domperidone or pimozide jointly with miltefo-sine; reducing side effect of decrease in body weight
06/10/2003US6576618 Cholesterol containing cationic liposome having gene encoding insulin like growth factor I
06/10/2003US6576613 Title inhibitors of urokinase
06/10/2003US6576464 Methods for providing differentiated stem cells
06/10/2003US6576439 Contacting protein of given sequence with a test compound and detecting modulating activity; drug screening; can use for treatment of inflammatory conditions
06/10/2003US6576437 Stimulus-inducible protein kinase complex and methods of use therefor
06/10/2003US6576434 Transport protein of given amino acid sequence; exposing cells that express the protein to compound; measuring ion transport; use in treatment of interleukin mediated atopic allergy, asthma and cystic fibrosis
06/10/2003US6576271 Method for inhibiting inflammation using bioflavonoids
06/10/2003US6576245 Primary package containing aqueous solution for parenteral administration comprising low molecular weight peptide-based thrombin inhibitor or salt,and having specified pH, sealed with rubber stopper or plunger containing bromobutyl rubber
06/10/2003US6576244 LT and CT in parenteral immunization methods against helicobacter infection
06/10/2003US6576236 Contacting T cell which expresses cytokine receptor gamma chain with anti-gamma chain antibody which binds to and transduces signal via gamma chain such that T cell responsiveness is stimulated
06/10/2003CA2413024A1 Antipyretic preparation containing xylitol
06/10/2003CA2303577C Qt dispersion and heart rate variability improvement with crf antagonists to prevent sudden death
06/10/2003CA2204437C Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids
06/10/2003CA2200651C Sodium alendronate preparation for local administration
06/10/2003CA2191795C Antisense oligonucleotide modulation of raf gene expression
06/10/2003CA2189603C Propiophenone derivative and processes for preparing the same
06/10/2003CA2120020C Air treatment plant for foodstuff comprising a trough with an adjustable width
06/10/2003CA2072047C Pharmaceutical compositions
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/09/2003WO2003002536A1 Unsymmetrical cyclic diamine compound
06/06/2003CA2436943A1 Hydantoin compounds useful as anti-inflammatory agents
06/06/2003CA2413479A1 Kit for reducing aching
06/05/2003WO2003046578A2 Method for the assessment and prognosis of sarcoidosis
06/05/2003WO2003046560A2 Self-assembly molecules
06/05/2003WO2003046185A1 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
06/05/2003WO2003046171A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof
06/05/2003WO2003046170A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof
06/05/2003WO2003046150A2 Glycoprotein remodeling using endoglycanases
06/05/2003WO2003046141A2 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
06/05/2003WO2003046124A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003WO2003045999A2 Human vanilloid receptor protein and polynucleotide sequence encoding same
06/05/2003WO2003045984A2 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
06/05/2003WO2003045977A2 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes
06/05/2003WO2003045974A2 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003WO2003045967A1 Aryl fused azapolycyclic compounds
06/05/2003WO2003045965A2 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
06/05/2003WO2003045952A2 Condensed camptothecins as antitumor agents
06/05/2003WO2003045951A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045940A2 Benzazepine derivatives and their use as 5-ht ligands
06/05/2003WO2003045938A1 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23
06/05/2003WO2003045937A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor
06/05/2003WO2003045929A1 Bicyclic derivative, process for producing the same, and use
06/05/2003WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003WO2003045925A1 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
06/05/2003WO2003045923A1 Preventives or remedies for alzheimer’s disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
06/05/2003WO2003045922A1 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies
06/05/2003WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003WO2003045920A1 4-aminoquinoline compounds
06/05/2003WO2003045918A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
1 ... 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 ... 1564